|
|
 |
|
| Test Name: | CYP2C9 & VKORC1 Genotyping for Warfarin Treatment |
| Compliance: | LDT |
| Test Description: | Warfarin is an anticoagulant medication commonly used to treat thrombosis. It may be prescribed for conditions such as stroke, deep vein thrombosis, heart valve replacement, and atrial fibrillation. Individuals who are sensitive to the medication are at risk of serious bleeding side effects and should receive a lower dose. The genetic variants VKORC1 and CYP2C9 have been shown to have a high correlation with warfarin use and the required dosage. |
| Methodology: | PCR-Sanger sequencing analysis of CYP2C9 gene |
| Gene Name: | CYP2C9 |
| Protein Name: | |
| Specimen Requirements: | EDTA Blood (5mL) |
| Storage Condition: | Ambient Temperature / 4℃ (if overnight is needed) |
| Turn Around Time: | 5 working days from day of specimen received |
| OMIM: | |
| Genetic Home Reference: | |
|
|
|
|
|
|
|
|
Shipping & Billing Information
|
Non-disclosure and Complaints
All data/information generated from within/related to HKMPDC and our customers are treated in strict confidence in accordance with the Personal Data (Privacy) Ordinance of Hong Kong. If you have a complaint, please contact us at the (852) 2986 1213 or email us at contact@hk-mpdc.com. All communications with HKMPDC would be dealt with in strict confidence.
Notice of Privacy Practices
This notice describes how medical information about you may be used and disclosed.
Personal health information or related information released to HKMPDC relating to the services requested may be subjected to re-disclosure by HKMPDC to health care providers, such as doctors, nurses, and others involved in the delivery of the services.
We may also disclose medical information about you to authorised public health or government officials for public health activities as required by law and accreditation body.
Copyright © 2013 香港分子病理檢驗中心 Hong Kong Molecular Pathology Diagnostic Centre Limited (HKMPDC). All Rights Reserved.
Information Updated 1 July, 2023.
|
|
|
|
